FDA approval is what will ultimately deliver the biggest spike in value to the company. Hard to see at this stage why that won't be forthcoming once the application is made given the safety and efficacy. In other words, by around this time next year Spontan could be in market in the US and the magnitude of that outcome cannot be understated. Also the company will be looking into a US listing given what is ahead. Of course, every chance the company may be made offers it cannot refuse ahead of such inflection points.
LTP Price at posting:
96.5¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)